The Royal Marsden
Drug development

In our DNA

While whole-genome profiling for childhood cancers remains the ultimate goal, young patients at The Royal Marsden are already benefiting from genetic tests.

Read more
Drug development

Carbon copies

The Royal Marsden has led the drive to bring biosimilars – near-identical replicas of vital drugs that are just as effective as the originals, yet cost far less – to more cancer patients

Read more
Drug development

70 years of innovation at The Royal Marsden

As the NHS celebrates its 70th birthday in July 2018, we take a look back at what The Royal Marsden has achieved in the fields of drug development, radiotherapy and surgery during that time.

Read more
Drug development

Q&A: Targeted drug trial

Dr Irene Chong, Consultant Clinical Oncologist, discusses ibrutinub and oesophageal cancers

Read more
Load more articles